Ibaraki, Japan

Yasuhiro Yasutomi

USPTO Granted Patents = 3 


Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yasuhiro Yasutomi: Innovator in Vaccine Development

Introduction

Yasuhiro Yasutomi is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of vaccine development, particularly in the fight against viral diseases. With a total of three patents to his name, Yasutomi's work focuses on innovative approaches to vaccine formulation and delivery.

Latest Patents

Yasutomi's latest patents include a recombinant Vaccinia virus as a dengue virus vaccine. This invention can be utilized as both a therapeutic and prophylactic agent in clinical settings. The recombinant Vaccinia virus is characterized by including all or part of a cDNA that encodes a non-structural protein from the dengue virus, along with an expression promoter. Another notable patent is a pharmaceutical composition for the treatment and/or prevention of hepatitis C. This invention aims to induce stronger cellular immunity to hepatitis C and provides effective means for completely eliminating the hepatitis C virus (HCV). The composition comprises a recombinant vaccinia virus and a recombinant vector, with specific characteristics that enhance immunity.

Career Highlights

Throughout his career, Yasutomi has worked with esteemed institutions such as the Tokyo Metropolitan Institute of Medical Science and the University of California. His research has focused on developing innovative solutions to combat viral infections, showcasing his dedication to public health.

Collaborations

Yasutomi has collaborated with notable colleagues, including Michinori Kohara and R Holland Cheng. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Yasuhiro Yasutomi stands out as a key figure in the field of vaccine innovation. His contributions to the development of vaccines for dengue and hepatitis C highlight his commitment to improving global health outcomes. His work continues to inspire future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…